2018
DOI: 10.1007/s00213-018-4946-0
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats

Abstract: In summary, the inhalation of THC or CBD, alone and in combination, produces approximately equivalent effects in male and female rats. This confirms the efficacy of the e-cigarette-based method of THC delivery in female rats.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

15
91
3

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 84 publications
(109 citation statements)
references
References 52 publications
15
91
3
Order By: Relevance
“…ENDS are relatively new for the field and are being used by multiple labs to vaporize and deliver various drugs to rodents via inhalation. Published work shows that ENDS can be used to vaporize and deliver nicotine (Javadi-Paydar et al 2019), THC (Nguyen et al 2016aJavadi-Paydar et al 2018, opiates (Vendruscolo et al 2018), stimulants (Nguyen et al 2017), or combinations of these drugs (Javadi-Paydar et al 2019) to rats on experimenter-determined schedules, and that these exposures produce expected blooddrug levels, relative to prior work using other systemic routes of drug administration. Furthermore, for many of these drugs, labs are working to establish reliable e-cigarette vapor self-administration using operant tasks that can be learned, extinguished, and altered according to drug concentrations in the vape solution.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…ENDS are relatively new for the field and are being used by multiple labs to vaporize and deliver various drugs to rodents via inhalation. Published work shows that ENDS can be used to vaporize and deliver nicotine (Javadi-Paydar et al 2019), THC (Nguyen et al 2016aJavadi-Paydar et al 2018, opiates (Vendruscolo et al 2018), stimulants (Nguyen et al 2017), or combinations of these drugs (Javadi-Paydar et al 2019) to rats on experimenter-determined schedules, and that these exposures produce expected blooddrug levels, relative to prior work using other systemic routes of drug administration. Furthermore, for many of these drugs, labs are working to establish reliable e-cigarette vapor self-administration using operant tasks that can be learned, extinguished, and altered according to drug concentrations in the vape solution.…”
Section: Discussionmentioning
confidence: 99%
“…Similar to other studies (Nguyen et al 2016a(Nguyen et al , 2016b(Nguyen et al , 2017Javadi-Paydar et al 2018Vendruscolo et al 2018) that delivered drugs through ENDS to rodents, we did not measure the drug concentration in the air of the chambers and in the fur of rats, or conduct an epidermal tissue biopsy. While nicotine vapor exposure in a chamber does not exclude uptake through skin/fur absorption or grooming, such effects seems to be negligible compared to inhalation effects observed in rodents following nicotine wholebody vapor exposure through ENDS (see Milano et al 2019 for a review).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Cannabis extracts rich in THC (CANTHC; 28.4% THC/1.1% CBD) or CBD (CANCBD; 1.96% THC/59.3% CBD) were heated to 60°C under constant stirring and dissolved in 80% propylene glycol/20% vegetable glycerol vehicle (VEH) at a concentration of 400 mg/ml based on previous studies [25,26]. Based on the certificate of analysis provided by NIDA, the final concentrations of THC and CBD in CANTHC were ~116.8 mg/ml and ~4.4 mg/ml, respectively.…”
Section: Drugsmentioning
confidence: 99%
“…Moreover, synthetic CB1 receptor agonists are known to recruit different intracellular signaling cascades (Laprairie et al, 2014(Laprairie et al, , 2016 and differences in pharmacokinetics due to the route of administration can dramatically influence the amount of fetal exposure (McLaughlin, 2018). More recently, a cannabis vapor delivery system has been introduced to more closely mimic the intrapulmonary route of administration that is most common among human cannabis users (Freels et al, 2020;Javadi-Paydar et al, 2018;Nguyen et al, 2016). This approach takes advantage of commercial 'e-cigarette' technology to deliver vaporized whole-plant cannabis extracts to rodents that results in pharmacologically and behaviorally relevant cannabinoid concentrations in plasma and brain tissue (Freels et al, 2020;Nguyen et al, 2016).…”
Section: Introductionmentioning
confidence: 99%